Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Plos One
|
February 18, 2015
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of irinotecan and its main metabolites in human plasma and its application in a clinical pharmacokinetic study
Elena Marangon, Bianca Posocco, Elisa Mazzega, et al.
Mass Spectrometry Reviews
|
August 18, 2015
Mass spectrometry in the pharmacokinetic studies of anticancer natural products
Sara Crotti, Bianca Posocco, Elena Marangon, et al.
Rapid Communications in Mass Spectrometry : RCM
|
May 26, 2007
Direct analysis of isopropylthioxanthone (ITX) in milk by high-performance liquid chromatography/tandem mass spectrometry
Renzo Bagnati, Giancarlo Bianchi, Elena Marangon, et al.
Chemical Communications (Cambridge, England)
|
February 15, 2003
Reactions of phenyldimethylsilyllithium with beta-N,N-dimethylaminoenones
Ian Fleming, Elena Marangon, Chiara Roni, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 13, 2009
Development and validation of a LC-MS/MS method for the determination of the novel oral 1,14 substituted taxane derivatives, IDN 5738 and IDN 5839, in mouse plasma and its application to the pharmacokinetic study
Elena Marangon, Cristiano Falcioni, Carla Manzotti, et al.
Journal of Mass Spectrometry : JMS
|
October 18, 2007
Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry
Elena Marangon, Federica Sala, Orazio Caffo, et al.
Journal of Mass Spectrometry : JMS
|
September 28, 2010
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel proteasome inhibitor CEP-18770 in human plasma and its application in a clinical pharmacokinetic study
Federica Sala, Elena Marangon, Renzo Bagnati, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
August 22, 2009
Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study
Federica Sala, Massimo Zucchetti, Renzo Bagnati, et al.
Plos One
|
February 24, 2018
A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6α-hydroxy-paclitaxel in human plasma: Development, validation and application in a clinical pharmacokinetic study
Bianca Posocco, Mauro Buzzo, Andrea Follegot, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
August 14, 2016
Nanocarriers in cancer clinical practice: a pharmacokinetic issue
Luciana Giodini, Francesco Lo Re, Davide Campagnol, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Plos One
|
February 18, 2015
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of irinotecan and its main metabolites in human plasma and its application in a clinical pharmacokinetic study
Elena Marangon, Bianca Posocco, Elisa Mazzega, et al.
Mass Spectrometry Reviews
|
August 18, 2015
Mass spectrometry in the pharmacokinetic studies of anticancer natural products
Sara Crotti, Bianca Posocco, Elena Marangon, et al.
Rapid Communications in Mass Spectrometry : RCM
|
May 26, 2007
Direct analysis of isopropylthioxanthone (ITX) in milk by high-performance liquid chromatography/tandem mass spectrometry
Renzo Bagnati, Giancarlo Bianchi, Elena Marangon, et al.
Chemical Communications (Cambridge, England)
|
February 15, 2003
Reactions of phenyldimethylsilyllithium with beta-N,N-dimethylaminoenones
Ian Fleming, Elena Marangon, Chiara Roni, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 13, 2009
Development and validation of a LC-MS/MS method for the determination of the novel oral 1,14 substituted taxane derivatives, IDN 5738 and IDN 5839, in mouse plasma and its application to the pharmacokinetic study
Elena Marangon, Cristiano Falcioni, Carla Manzotti, et al.
Journal of Mass Spectrometry : JMS
|
October 18, 2007
Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry
Elena Marangon, Federica Sala, Orazio Caffo, et al.
Journal of Mass Spectrometry : JMS
|
September 28, 2010
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel proteasome inhibitor CEP-18770 in human plasma and its application in a clinical pharmacokinetic study
Federica Sala, Elena Marangon, Renzo Bagnati, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
August 22, 2009
Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study
Federica Sala, Massimo Zucchetti, Renzo Bagnati, et al.
Plos One
|
February 24, 2018
A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6α-hydroxy-paclitaxel in human plasma: Development, validation and application in a clinical pharmacokinetic study
Bianca Posocco, Mauro Buzzo, Andrea Follegot, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
August 14, 2016
Nanocarriers in cancer clinical practice: a pharmacokinetic issue
Luciana Giodini, Francesco Lo Re, Davide Campagnol, et al.
Page
of 4